Gilead Sciences
GILD
#80
Rank
C$302.13 B
Marketcap
C$243.59
Share price
1.60%
Change (1 day)
39.71%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): C-$4.54

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C-$4.44. In 2025 the company made an earnings per share (EPS) of C$9.80 an increase over its 2024 EPS that were of C$0.54.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.54-146.29%
2025C$9.801702.63%
2024C$0.54-91.65%
2023C$6.5123.98%
2022C$5.25-25.86%
2021C$7.084850%
2020C$0.14-97.64%
2019C$6.070.9%
2018C$6.0118.71%
2017C$5.06-64.88%
2016C$14.42-18.45%
2015C$17.6855.28%
2014C$11.39296.02%
2013C$2.8817.89%
2012C$2.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.56-315.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.02-122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$8.37-288.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.20-1,096.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.87-660.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$3.38-176.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$8.43-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$22.42-605.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-132.03%๐Ÿ‡บ๐Ÿ‡ธ USA